Organophosphorus compounds preferentially affect second messenger systems coupled to M2/M4 receptors in rat frontal cortex

Brain Research Bulletin

Volumn 39, Issue 1, 1996, Pages 49-55

  Ward, Thomas R ^a   Mundy, William R ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Brain; cAMP; Chlorpyrifos; Malathion; Muscarinic receptor subtypes; Parathion

Indexed keywords

ACETYLCHOLINESTERASE; ADENYLATE CYCLASE; ATROPINE; CHLORPYRIFOS; CHOLINERGIC RECEPTOR; CYCLIC AMP; FORSKOLIN; MALAOXON; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; ORGANOPHOSPHORUS COMPOUND; PARATHION; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; ENZYME INHIBITION; FRONTAL LOBE; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0030025861     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/0361-9230(95)02044-6     Document Type: Article

References (39)

1. Abdallah, E. A. M.; Jett, D. A.; Eldefrawi, M. E.; Eldefrawi, A. T. Differential effects of paraoxon on the M3 muscarinic receptor and its effector system in rat submaxillary gland cells. J. Biochem. Toxicol. 7:125-132; 1992.
2. Allgaier, C.; Choi, B. K.; Hertting, G. Muscarine receptors regulating electrically evoked release of acetylcholine in hippocampus are linked to pertussis toxin-sensitive G proteins but not to adenylate cyclase. J. Neurochem. 61:1043-1049; 1993.
3. Alvarez, R.; Daniels, D. V. A separation method for the assay of adenylylcyclase, intracellular cyclic AMP, and cyclic-AMP phosphodiesterase using tritium-labeled substrates. Analyt. Biochem. 203:76-82; 1992.
4. Anderson, D. J.; McKinney, M. Muscarinic M2 receptor-mediated cyclic AMP reduction in mechanically dissociated rat cortex. Brain Res. 475:28-34; 1988.
5. Ashkenazi, A.; Winslow, J. W.; Peralta, E. G.; Peterson, G. L.; Schimerlik, M. I.; Capon, D. J.; Ramachandran, J. An M2 muscarinic receptor subtype coupled to both adenyl cyclase and phosphoinositide turnover. Science 238:672-675; 1987.
6. Bakry, N. M. S.; El-Rashidy, A. H.; Eldefrawi, A. T.; Eldefrawi, M. E. Direct actions of organophosphate anticholinesterases on nicotinic and muscarinic acetylcholine receptors. J. Biochem. Toxicol. 3:235-259; 1988.
7. Berridge, M. J.; Downes, C. P.,; Handey, M. R. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem. J. 206:587-595; 1988.
8. Bonner, T. I. The molecular basis of muscarinic receptor diversity. Trends Neurosci. 12:148-151; 1989.
9. Bradford, M. M. A rapid and sensitive method for the quantitation of protein dye-binding. Anal. Biochem. 12:248-254; 1976.
10. Brown, E.; Kendall, D. A.; Nahorski, S. R. Inositol phospholipid hydrolysis in rat cerebral cortical slices. I. Receptor characterization. J. Neurochem. 42:1379-1387; 1984.
11. Buckley, N. J.; Bonner, T. I.; Brann; M. R. Localization of a family of muscarinic receptor mRNAs in rat brain. J. Neurosci. 8:4646-4652; 1988.
12. Chaudhuri, J.; Chakraborti, T. K.; Chanda, S.; Pope, C. N. Differential modulation of organophosphate-sensitive muscarinic receptors in rat brain by parathion and chlorpyrifos. J. Biochem. Toxicol. 8:207-216; 1993.
13. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:3099-3108; 1973.
14. 3H]cis-methyldioxolane labels preferentially but not exclusively agonist high affinity states of muscarinic M2 receptors. Naunyn-Schmeideberg's Arch. Pharmacol. 335:372-377; 1987.
15. Eldefrawi, A. T.; Jett, D.; Eldefrawi, M. E. Direct actions of organophosphate anticholinesterases on muscarinic receptors. In: Chambers, J. E.; Levi, P. E., eds. Organophosphates: Chemistry, fate, and effects. New York: Academic Press; 1992:257-270.
16. Forray, C.; El-Fakahany, E. E. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex. Mol. Pharmacol. 37:893-902; 1990.
17. Huff, R. A.; Abou-Donia, M. B. cis-Methyldioxolane specifically recognizes the m2 muscarinic receptor. J. Neurochem. 62:388-391; 1994.
18. Huff, R. A.; Corcoran, J. J.; Anderson, J. K.; Abou-Donia, M. B. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum. J. Pharmacol. Exp. Ther. 269:329-335; 1994.
19. Jett, D. A.; Abdallah, E. A. M.; El-Fakahany, E. E.; Eldefrawi; M. E.; Eldefrawi, A. T. High-affinity activation by paraoxon of a muscarinic receptor subtype in rat brain striatum. Pest. Biochem. Physiol. 39:149-157; 1991.
20. Karczmar, A. G. Acute and long lasting central actions of organophosphorus agents. Fund. Appl. Toxicol. 4:S1-S17; 1984.
21. Katz, L. S.; Marquis, J. K. Modulation of central muscarinic receptor binding in vitro by ultralow levels of the organophosphate paraoxon. Toxicol. Appl. Pharmacol. 101:114-123; 1989.
22. Katz, L. S.; Marquis, J. K. Organophosphate-induced alterations in muscarinic receptor binding and phosphoinositide hydrolysis in the human SK-N-SH cell line. Neurotoxicol. 13:365-378; 1992.
23. Lambert, D. G.; Burford, N. T.; Nahorski, S. R. Muscarinic receptor subtypes: Inositol phosphates and intracellular calcium. Biochem. Soc. Trans. 20:130-135; 1992.
24. Levey, A. L. Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sciences 52:441-448; 1993.
25. Marchi, M.; Ruelle, A.; Andrioli, G. C.; Raiteri, M. Pirenzepine-insensitive muscarinic autoreceptors regulate acetylcholine release in human neocortex. Brain Res. 520:347-350; 1990.
26. McKinney, M.; Anderson, D.; Vella-Rountree, L. Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems. Mol. Pharmacol. 35:39-47; 1989.
27. 3H]acetylcholine release from rat cortical synaptosomes. J. Neurosci. 5:1202-1207; 1985.
28. Savage, E. P.; Keefe, T. J.; Mounce, L. M.; Heaton, R. K.; Lewis, J. A.; Burcar, P. J. Chronic neurological sequelae of acute organophosphate pesticide poisoning. Arch. Environ. Hlth. 43:38-45; 1988.
29. 3 inhibition of agonist stimulated inositol phosphate accumulation. Role of calcium, G-proteins, phospholipase C and protein kinase C. Biochem. Pharmacol. 47:1417-1425; 1994.
30. 2 muscarinic receptors of rat heart have high affinity for organophosphorus anticholinesterases. Toxicol. Appl. Pharmacol. 103:474-481; 1990.
31. Sumerford, W. T.; Hayes Jr., W. J.; Johnston, J. M.; Walker, K.; Spillane, J. Cholinesterase response and symptomology from exposure to organic phosphorus insecticides. Arch. Indust. Hyg. Occup. Med. 7:383-398; 1953.
32. Taylor, P. Anticholinesterase agents. In: Goodman, A. G.; Goodman, L. S.; Rail, T. W.; Murad, F., eds. Goodman and Gilman's The pharmacological basis of therapeutics. New York: Macmillan; 1985:110-129.
33. 3H]acetylcholine release in rat hippocampus. J. Pharmacol. Exp. Ther. 251:1039-1044; 1989.
34. 3H]cismethyldioxolane. J. Pharmacol. Exp. Ther. 229:747-755; 1984.
35. Volpe, L. S.; Biagioni, T. M.; Marquis, J. K. In vitro modulation of bovine caudate muscarinic receptor number by organophosphates and carbamates. Toxicol. Appl. Pharmacol. 78:226-234; 1985.
36. Ward, T. R.; Ferris, D. J.; Tilson, H. A.; Mundy, W. R. Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic re-ceptors. Toxicol. Appl. Pharmacol. 122:300-307; 1993.
37. Watson, M.; Roeske, W. R.; Vickroy, T. W.; Smith, T. L.; Aikyama, K.; Gulya, K.; Duckles, S. P.; Serra, M.; Adern, A.; Norberg, A.; Gehlert, D. R.; Wamsley, J. K.; Yamamura, H. I. Biochemical and functional basis of putative muscarinic receptor subtypes and its implications. Trends Pharmacol. Sci. Suppl. 7:46-55; 1986.
38. Weiler, M. H. Characterization of muscarinic receptors modulating acetylcholine release in the rat neostriatum. Experientia Suppl. 57:204-211; 1989.
39. Yamamura, H. I.; Snyder, S. Muscarinic cholinergic binding in rat brain. Proc. Natl. Acad. Sci. USA 71:1725-1729; 1974.